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Background. Hepatectomy, an important treatmentmodality for liver malignancies, has high perioperative morbidity andmortality
rates. Safe, comprehensive criteria for selecting patients for hepatectomy are needed. Since June 2011, we have used a cut-off value
of ≧ 0.05 for future liver remnant plasma clearance rate of indocyanine green as a criterion for hepatectomy. The aim of this study
was to verify the validity of this criterion.Methods. From June 2011 to December 2015, 212 hepatectomies were performed in Tenri
Yorozu Hospital. Of these 212 patients, 107 who underwent preoperative computed tomography imaging volumetry, indocyanine
green clearance test, and hepatectomy (excluding partial resection or enucleation) were retrospectively analyzed. Results. There
was no postoperative mortality. Posthepatectomy liver failure occurred in 59 patients (55.1%) (International Study Group of Liver
Surgery Grade A: 43 cases (40.2%), Grade B: 16 cases (15.0%), and Grade C: no cases). Operative morbidity greater than Clavien-
Dindo Grade 3 occurred in 23 patients (21.5%). A low future liver remnant plasma clearance rate of indocyanine green was a good
predictor for Grade B cases (area under curve = 0.804; 95% confidence interval, 0.712–0.895). Conclusion. Liver remnant plasma
clearance rate of indocyanine green is a valid criterion for hepatectomy.
1. Introduction
Hepatectomy is an important treatment modality for liver
malignancies. On the other hand, postoperative morbidity
and mortality rates are still high. Posthepatectomy liver
failure (PHLF), one of the most critical forms of morbidity,
is closely correlated with postoperative mortality.
In 1993, Makuuchi’s criteria [1] were proposed for hep-
atectomy in patients with underlying liver diseases. These
criteria are based on presence or absence of ascites, preop-
erative total bilirubin concentration, and indocyanine green
(ICG) retention rate at 15 minutes and have since been widely
accepted in Japan. Makuuchi’s criteria are probably appropri-
ate for patients with basically healthy liver too and are used
by many surgeons; however, patients who are ineligible for
hepatectomy according to Makuuchi’s criteria are frequently
encountered. The safety of hepatectomy in such patients is
still controversial. In 1980, Takasaki et al. reported that future
liver remnant plasma clearance rate of ICG (rICGK) was
useful for predicting posthepatectomy liver function [2]. It
is easily calculated as follows: preoperative ICGK × % future
remnant liver volume (RLV) and is also widely used in Japan.
Nagino et al. and Yokoyama et al. reported that rICGK less
than 0.05 is associated with a high incidence of perioperative
mortality after hepatectomy for biliary cancer [3, 4], but the
significance of rICGK on hepatectomy for other diseases has
not been fully evaluated.
2. Methods
2.1. Patients. From June 2011 to December 2015, 212 patients
underwent hepatectomy in Tenri Yorozu Hospital. Eighty-
nine patients who had undergone limited resection (partial
resection or enucleation) and 16who had undergone different
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Table 1: Patient characteristics.
Variables (𝑛 = 107)
Age, years 69 (38–86)
Sex, male, % 67.3
HBs antigen+, % 12.1
HCV antibody+, % 14.0
ICGK 0.151 (0.069–0.264)
ICGR15, % 11.9 (1.9–35.4)
TLV, mL 1181 (735–2169)
% RLV 59.3 (34.7–93.7)
rICGK 0.088 (0.050–0.199)
T-Bil, mg/dL 0.7 (0.2–2.5)
Alb, g/dL 3.9 (1.8–5.2)
Plt, 104/𝜇L 20.5 (8.3–72.0)
PT-INR 1.03 (0.93–1.93)
eGFR (mL/min) 76.0 (6.5–185.6)
Blood loss, mL 867 (50–7750)
Operation time, min 361 (151–748)
Indications for hepatectomy (𝑛 = 107)
Hepatocellular carcinoma 52
Metastatic liver tumor 29
Cholangiocarcinoma 14
Others 12
HBs antigen+: hepatitis B virus surface antigen positive, HCV antibody+:
hepatitis C virus antibody positive, ICGR15: indocyanine green retention rate
at 15 minutes, TLV: total liver volume, % RLV: remnant liver volume/total
liver volume (%), T-Bil: total bilirubin, Alb: albumin, Plt: platelet count,
PT-INR: international normalized ratio of prothrombin time, and eGFR:
estimated glomerular filtration rate.
Table 2: Type of hepatectomy.











Both trisectionectomies were right trisectionectomies. Segmentectomy
included S3 (two patients), S2, S5, S6, and S5 + 6 (one patient each).
types of hepatectomy than had been planned preoperatively
by computed tomography (CT) imaging were excluded
because lack of data on future RLV prevented assessment of
the validity of the rICGK ≧ 0.05 criterion in these patients.
Thus, 107 patients who had undergone hepatectomy based
on preoperative planning by computed tomography (CT)
imaging volumetry were included in this study.
Patient characteristics, indications for hepatectomy, and
types of hepatectomy are shown in Tables 1 and 2.
2.2. Resection Criteria. Only patients whose rICGK ≧ 0.05
were considered eligible for hepatectomy. Preoperative CT
imaging volumetry was performed using SYNAPSE VIN-
CENT version 2.0 (FUJIFILM, Tokyo, Japan). Preoperative
portal embolism was performed in eight patients whose
rICGK was less than 0.05. After this procedure, the rICGK
became greater than 0.05 in all eight of these patients and
all of them subsequently underwent hepatectomy. We have
included these eight patients in this study.
2.3. Clinical Data Assessed. The clinical data we assessed
included the following: age, sex, ICGK, ICG retention rate
at 15 minutes (ICGR15), total liver volume, % RLV (future
remnant liver volume/total liver volume − tumor volume ×
100), rICGK, serum total bilirubin (T-Bil), serum albumin
(Alb), platelet count (Plt), international normalized ratio of
prothrombin time (PT-INR), estimated glomerular filtration
rate (eGFR), intraoperative blood loss, and operation time.
2.4. Outcomes Evaluated. We assessed postoperative mor-
tality and morbidity (greater than Clavien-Dindo Grade 3),
PHLF, and postoperative hospital stay. PHLF was categorized
according to the criteria of the International Study Group of
Liver Surgery (ISGLF) [5]. Patients were also categorized as
meeting or not meeting Makuuchi’s criteria.
2.5. Statistical Analysis. Data are expressed as median and
range. Differences between two groups were assessed by the
Mann-Whitney 𝑈 test and 𝜒2 test. Differences between three
groups were assessed by one-way analysis of valiance and the
Tukey multiple comparison procedure. Predictive value was
assessed by calculating the area under the receiver operator
characteristic (ROC) curve (AUC). Statistical analysis was
performedusing SPSS Statistics version 22.0 (IBM,NY,USA).
A 𝑃 value < 0.05 was considered statistically significant.
2.6. Study Design. The study design was approved by our
institution’s ethics review board (approval number 739) and
the need for informed consent was waived in view of its
retrospective nature.
3. Results
There was no postoperative mortality. There was one in-
hospital death that was not directly related to hepatectomy
(it was due to pleural dissemination of renal cell carcinoma).
PHLF was identified in 59 patients (55.1%), being Grade
A in 43 (40.2%), B in 16 (15.0%), and C in none. Patient
characteristics according to PHLF Grade A or Grade B and
absence of PHLF (non-PHLF) are shown in Table 3. There
were significant differences between these three groups in
%RLV, rICGK, operative blood loss, and operation time.
A significant difference was also observed between PHLF
Grades A and B for rICGK (Figure 1). A low rICGK was
a good predictor of development of PHLF Grade B (AUC,
0.804; 95% confidence interval, 0.712–0.895)Theoptimal cut-
off value of rICGKwas 0.073 for predicting both PHLFGrade
B (sensitivity, 0.812 specificity, 0.736) and PHLF all grades
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Table 3: Patient characteristics according to PHLF grade.
Variables Non-PHLF (𝑛 = 48) PHLF Grade A (𝑛 = 43) PHLF Grade B (𝑛 = 16) 𝑃 value
Age, years 69 (38–82) 68 (40–86) 69 (56–93) 0.59
Sex, male, % 75.0 55.8 75 0.12
HBs antigen+, % 14.5 11.6 6.3 0.68
HCV antibody+, % 10.4 11.6 31.3 0.10
ICGK 0.154 (0.069–0.212) 0.156 (0.091–0.264) 0.137 (0.085–0.211) 0.21
ICGR15, % 9.9 (4.2–35.4) 10.2 (1.9–25.6) 12.9 (4.2–27.8) 0.39
TLV, mL 1214 (786–2025) 1133 (735–2086) 1320 (829–2169) 0.39
% RLV 68.9 (40.5–93.7) 55.9 (34.7–87.0) 44.0 (37.2–80.2) <0.001
rICGK 0.095 (0.053–0.199) 0.079 (0.050–0.153) 0.067 (0.050–0.088) <0.001
T-Bil, mg/dL 0.5 (0.2–2.5) 0.7 (0.3–1.9) 0.7 (0.4–2.2) 0.74
Alb, g/dL 4.1 (1.8–5.2) 4.1 (2.6–4.7) 3.9 (3.0–4.7) 0.31
Plt, 104/𝜇L 19.4 (8.3–72.0) 17.0 (9.7–41.5) 17.7 (8.6–45.5) 0.68
PT-INR 1.03 (0.93–1.93) 1.03 (0.94–1.35) 1.06 (0.94–1.31) 0.93
eGFR (mL/min) 75.8 (53.2–124.4) 74.1 (6.5–186.0) 69.3 (38.9–120.4) 0.54
Blood loss, mL 440 (50–2600) 500 (70–7750) 1385 (230–3400) 0.047
Operation time, min 328 (151–654) 348 (204–620) 401 (286–748) 0.02
𝑃 values between the three groups were assessed by one-way analysis of variance and the Tukey multiple comparison procedure.
Table 4: Postoperative outcomes according to PHLF grade.
ALL (𝑛 = 107) Non-PHLF (𝑛 = 48) PHLF Grade A (𝑛 = 43) PHLF Grade B (𝑛 = 16)
Postoperative hospital stay (days) 16 (9–186) 14.5 (9–70) 16 (10–123) 34.5 (16–186)
Postoperative morbidity (≧G3), % 21.5 8.3 27.9 43.7
Postoperative morbidity greater than Clavien-Dindo Grade 3 was evaluated.
(sensitivity, 0.525 specificity, 0.875) (Figure 2): patients whose
rICGK was greater than 0.09 did not develop PHLF Grade B
(Figure 3).
Patients who developed PHLF Grade B had significantly
longer postoperative hospital stays (14.5 versus 43.7 days,
𝑃 < 0.001) and significantly higher rates of morbidity great-
er than Clavien-Dindo Grade 3 (8.3 versus 43.7%, 𝑃 =
0.007) than those who did not develop PHLF. There were no
significant differences in postoperative hospital days and rates
of morbidity greater than Clavien-Dindo Grade 3 between
PHLF Grade A and non-PHLF groups (16.5 versus 14.5 days,
𝑃 = 0.429; 27.9 versus 8.3%, 𝑃 = 0.062) (Table 4).
The 29 patients who did not meet Makuuchi’s criteria
had significantly higher rates than those who did meet this
criterion of developing PHLF (𝑃 = 0.016), but not of devel-
oping PHLF Grade B (𝑃 = 0.054) or morbidity greater than
Clavien-Dindo Grade 3 (𝑃 = 0.350) (Figure 4).
4. Discussion
Therewas no postoperativemortality in this study. According
to a Japanese national database, the perioperativemortality of
hepatectomy performed for more than one segment (except
for a lateral segment) is 4.0% [6]. Thus, the rICGK ≧ 0.05
criterion appears to be safe regarding zero mortality. How-
ever, there was a high incidence of PHLF. Previous studies
have reported the incidence of PHLF as 9.0%–39.6% [7, 8].
Because patient characteristics have varied between studies, it
is not valid to simply compare our findingswith those of other
studies; however, this is a noteworthy issue. Many of the cases
of PHLF in the present study were PHLF Grade A, which
had relatively little influence on the patients’ postoperative
course. However, patients who developed PHLF Grade B
had a high morbidity rate and longer postoperative hospital
stay. Because major operative blood loss and long operating
time are considered to contribute to development of PHLF,
surgeons should try to minimize blood loss and improve
their surgical techniques. A low rICGK had good predictive
value for development of PHLF Grade B in this study. The
optimal cut-off value was 0.073 for predicting PHLF Grade
B and patients with rICGK ≧ 0.09 did not have any severe
PHLF in our series. Because rICGK was used not to predict
PHLF but to assess the eligibility for hepatectomy in our
series, we think these values are not directly meaningful, but
these findings are consistent with our clinical experience;
Thus, patients with higher rICGK may not be at risk of
severe PHLF and, in patients with rICGK < 0.07, more
careful perioperative management should be performed to
avoid PHLF.There was also a high incidence of postoperative
morbidity greater than Clavien-Dindo Grade 3, whichmay at
least in part be attributable to our perioperative management
policy. We rarely place prophylactic drains after hepatectomy
and perform CT scans routinely on postoperative Day 7. We
frequently perform percutaneous drainage when we suspect
a fluid collection. This policy results in a relatively high
frequency of postoperative percutaneous drainage and these
cases are counted as postoperative morbidity Grade 3 even
when they do not actually have an infection or biliary leak.
We consider the rICGK ≧ 0.05 criterion to be more
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P = 0.522 P = 0.088
Figure 1: Distribution of factors significantly associated with development of PHLF. The rICGK of patients who developed PHLF Grade B
was significantly lower than that of others. Blood loss volume is greater and operation time is longer in the PHLF Grade B than Grade A
group, although not significant.
who did not meet Makuuchi’s criteria did meet the rICGK ≧
0.05 criterion. Although these patients tended to have poorer
postoperative outcomes than patients who did meet Maku-
uchi’s criteria, this difference was not significant. How far we
can expand the indications for hepatectomy is controversial.
Iguchi and colleagues reported results of hepatectomy for
HCC based on the criterion of rICGK more than 0.03 [8]. In
their study, patients whose rICGK was less than 0.05 had a
significantly higher incidence and greater severity of PHLF
than patients whose rICGK was more than 0.05. However,
these two groups did not differ significantly in perioperative
mortality or long-term oncological outcomes.
Patients with lower rICGK have a higher operative
risk. However, because hepatectomy is the only potentially
curative treatment modality for many liver malignancies,
it is difficult to determine the optimal operative risk. The
appropriate lower limit for rICGKmay be different according
to the underlying disease; we had too few patients in this
study to assess this possibility.
In 2011, PHLF grading was proposed by the ISGLF. Since
then, cross-sectional research on PHLF has become possible
and such studies are increasingly being performed. Further
accumulation of data and prospective studies investigating

































Figure 2: Receiver operating characteristic curve of rICGK for prediction of PHLF. Low rICGK has high predictive value for development
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Figure 3: Histogram showing relationship between rICGK and PHLF Grade B. Patients whose rICGK was more than 0.09 did not develop






































Within (n = 78) Beyond (n = 29) Within (n = 78) Beyond (n = 29)
Figure 4: Postoperative morbidity according to Makuuchi’s criterion. Patients who met Makuuchi’s criterion had lower incidences of severe
PHLF and postoperative morbidity than those who did not, although not significant.
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This study has several limitations. It was a retrospective
study and factors such as performance status and comorbidi-
ties were considered when assessing operative indications.
Thus, some poor risk patients may have been excluded. The
small sample size resulted in low statistical power for rare
morbidities such as PHLF Grade C.
In conclusion, the rICGK ≧ 0.05 criterion is a sufficiently
broad and safe criterion for selecting patients with various
diseases for hepatectomy.
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